Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: | Musculoskeletal | Neurology | Family Medicine
Search Medical Condition
Parkinson's Disease Clinical Trials
A listing of Parkinson's Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Found (441) clinical trials
Effect of LY3154207 on Cognition in Mild-to-Moderate Parkinson’s Disease Dementia (PDD)
Multicenter, randomized, double-blind, parallel-group, placebo-controlled, fixed-dosage, Phase 2a study comparing 3 dosages of LY3154207
A Washington University medical research study seeks participants with Parkinson’s disease (PD) & Psychotic Symptoms
The purpose of the research study is to see if an investigational drug will help patients with Parkinson’s disease related psychosis. Individual participation lasts for about 11 weeks. There are approximately 8 study visits. Each visit lasts anywhere from 3 to 6 hours. There will also be phone calls to ...
Parkinson’s Disease
People with Parkinson’s disease are asked to participate in a research study being conducted by Montefiore Medical Center.
Parkinson's Disease
Do you or a loved suffer from Parkinson’s disease? Wake Research Associates is enrolling volunteers with Parkinson’s in a clinical research study.
A 4-Week Study of the Safety Efficacy and Pharmacokinetics of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in Subjects With Parkinson's Disease and Excessive Sleepiness
This study is a 4-week, multicenter, randomized, double-blind, placebo-controlled, ascending dose, 4-period crossover study designed to evaluate the safety, tolerability, efficacy, and PK of JZP-110 (75, 150, and 300 mg) in the treatment of excessive sleepiness in adult subjects with idiopathic PD.
Parkinson’s disease patients and their caregivers are needed for a Washington University School of Medicine research study.
Dr. Kevin Black will look at the safety and effectiveness of an investigational drug compared to placebo (inactive substance) in the treatment of Parkinson’s disease with psychosis. Participation in this study may last up to 12 weeks. There will be a screening visit lasting about 3 hours and up to ...
Parkinson’s Disease - Mild to moderate symptoms
Parkinson’s disease (PD) affects millions of people all over the world. Dealing with it may seem daunting and frustrating. Medications can help manage some of the symptoms like the shaking and jerking, but over time they may not seem to work as well. We’re conducting a study of an investigational ...
Do you have Parkinson’s disease?
Dr. Brad Racette will look at an investigational inhaler method for taking medication for Parkinson’s disease (PD). There are up to 7 outpatient office visits that will take 1 to 5 hours each. Participants will receive study drug or a placebo by an inhaler. Compensation is provided. Risks and benefits ...
An Open-Label Trial Of Oral Selegiline 5 Or 10 Mg And Tadalafil 2.5 Mg Co-Administration To Male Patients With Parkinson's Disease And Moderate Erectile Dysfunction.
The purpose of this study is to see if selegiline and tadalafil (generic for Cialis®) results in an improvement in Erectile dysfunction (ED) in male patients with Parkinson's disease (PD) and moderate ED. Male PD patients who have an incomplete response to tadalafil alone will be given both medications to ...
Parkinson's Disease Study
A Phase 1B, 2-Period, Open Label, Multicenter, Dose Escalation study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of PF-06649751 in subjects with Parkinson’s disease and motor fluctuations.
